Until experts know that JN.1 does not appear to cause a serious infection in most people, although a severe case can make one feel “bad for three or four days,” he said. Schaffner said. Symptoms of a JN.1 infection are similar to those that cause earlier covid variants, they can include fiber, body aches and fatigue.
To protect yourself from infection and serious infection, experts recommend the use of masks, improve indoor ventilation as long as possible, keep it at home if indoors, and leave the vacuum as recently as possible against covid.
Preliminary investigations show that the updated vaccines against COVID-19 launched in September have produced anticuerpos effective against JN.1, which has a relationship, also, with the XBB.1.5 variant, for all that will be designed to vaccines. People aren’t stacking as much anticipation against JN.1 as they did for XBB.1.5, but either way, the levels should reduce the risk.
“Between those who are contagious or who recently received a rescue dose, cruzada protection against JN.1 should be pretty decent, based on our laboratory studies,” said David Ho, a Colombia University virologist led by investigation concerning JN.1 and covid vaccines, it will be published as a draft article for the December principles. Rapid testing also follows a valid tool, and the CDC confirms that testing is indeed on the market to detect the JN.1 variant.
There are indications that COVID-19 cases are increasing further. The week of December 10, there were just under 26,000 coronavirus-related hospitalizations, an increase of 10 from the previous week’s 23,000 cases. But hospitalization rates for covid are much lower than during the increase in the first year of omicron in 2022 and, now, it is only the mitad of what was during the peak of the “tripledemic” of the past winter, when you are a surgeon for COVID-19, flu and RSV at the same time.
